Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00855010 · ClinicalTrials.gov registry record · NA
Pioglitazone on Pancreatic Steatosis and Bone Health
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT00855010 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 42 participants.
The verdict
NCT00855010, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
Randomized, double blind, placebo controlled trial evaluating the effect of pioglitazone on pancreatic fat content and bone turnover markers.
Interventions
- DRUG placebo
- DRUG pioglitazone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2009-02 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00855010
The ClinicalTrials.gov registry entry for NCT00855010 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00855010 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00855010 about?
NCT00855010 is a clinical study titled "Pioglitazone on Pancreatic Steatosis and Bone Health". Randomized, double blind, placebo controlled trial evaluating the effect of pioglitazone on pancreatic fat content and bone turnover markers.
What is the current status of trial NCT00855010?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2009-02. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00855010?
The interventions under investigation include: placebo (DRUG), pioglitazone (DRUG).
Who is sponsoring clinical trial NCT00855010?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.